Research lines into asthma

Reading time: 1 min

There have been important advances in the last few years in the study of the mechanisms involved in the presentation of the different forms of asthma.

Specifically, research is being carried out in order to determine the so-called asthma phenotypes. A phenotype refers to certain patient groups with asthma that have similar clinical and inflammatory characteristics. Research is currently being carried out to study the phenotypes better and find more personalised treatments for the patients.

Research into new treatments. The advances in the understanding of the disease have led to the development of new drugs with novel mechanisms of action involved in the inflammatory airways of the asthma. It is the case of the so-called biological drugs, which are monoclonal antibodies that act by blocking certain proteins involved in development of asthma. Multicentre studies are currently being conducted on patients in order to test their effectiveness and safety and that will very likely be available in the future to treat this type of patient. Some examples of these are:

  • Antibodies against ILE: Quilizumab.
  • Antibodies against IL5: Benralizumab, Reslizumab.
  • Antibodies against IL13: Lebrikizumab, Tralokinumab.
  • Antibodies against IL4: Dupilumab.

Substantiated information by:

Alejandra Lopez Giraldo
Antonio Valero Santiago
Irina Bobolea
Rosa Cortés Aguilar

Published: 20 February 2018
Updated: 20 February 2018

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.


Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.